Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Kaposi's sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised.
Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
The report details the trend, potential and market size of Kaposi's Sarcoma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kaposi's Sarcomamarket, defines the market attractiveness level of Kaposi's Sarcoma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kaposi's Sarcoma industry, describes the types of Kaposi's Sarcoma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kaposi's Sarcoma market and the development prospects and opportunities of Kaposi's Sarcoma industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kaposi's Sarcoma market in Chapter 13.
By Player:
Roche
GlaxoSmithKline
Pfizer
Eli Lilly and Company
Bristol Myers Squibb
CytRx
Cytori Therapeutics
Aphios
Johnson and Johnson
Merck
By Type:
Classic
Endemic
Immunosuppresion Therapy-related
Epidemic
By End-User:
Hospital
Cancer Research Institution
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kaposi's Sarcoma Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kaposi's Sarcoma Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kaposi's Sarcoma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kaposi's Sarcoma Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kaposi's Sarcoma Market Analysis and Outlook to 2022
-
7.1 Global Kaposi's Sarcoma Consumption (2017-2022)
-
7.2 United States Kaposi's Sarcoma Consumption (2017-2022)
-
7.3 Europe Kaposi's Sarcoma Consumption (2017-2022)
-
7.4 China Kaposi's Sarcoma Consumption (2017-2022)
-
7.5 Japan Kaposi's Sarcoma Consumption (2017-2022)
-
7.6 India Kaposi's Sarcoma Consumption (2017-2022)
-
7.7 South Korea Kaposi's Sarcoma Consumption (2017-2022)
8 Region and Country-wise Kaposi's Sarcoma Market Analysis and Outlook to 2028
-
8.1 Global Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.2 United States Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.3 Europe Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.4 China Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.5 Japan Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.6 India Kaposi's Sarcoma Consumption Forecast (2022-2028)
-
8.7 South Korea Kaposi's Sarcoma Consumption Forecast (2022-2028)
9 Global Kaposi's Sarcoma Market Outlook by Types and Applications to 2022
-
9.1 Global Kaposi's Sarcoma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Classic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Endemic Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunosuppresion Therapy-related Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Epidemic Consumption and Growth Rate (2017-2022)
-
9.2 Global Kaposi's Sarcoma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Institution Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Kaposi's Sarcoma Market Outlook by Types and Applications to 2028
-
10.1 Global Kaposi's Sarcoma Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Classic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Endemic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunosuppresion Therapy-related Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Epidemic Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kaposi's Sarcoma Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Kaposi's Sarcoma Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kaposi's Sarcoma Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kaposi's Sarcoma Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kaposi's Sarcoma Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kaposi's Sarcoma Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Kaposi's Sarcoma Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Kaposi's Sarcoma Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Kaposi's Sarcoma Product and Service
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Details
-
14.4.2 Eli Lilly and Company Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly and Company Kaposi's Sarcoma Product and Service
-
14.5 Bristol Myers Squibb
-
14.5.1 Bristol Myers Squibb Company Details
-
14.5.2 Bristol Myers Squibb Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol Myers Squibb Kaposi's Sarcoma Product and Service
-
14.6 CytRx
-
14.6.1 CytRx Company Details
-
14.6.2 CytRx Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 CytRx Kaposi's Sarcoma Product and Service
-
14.7 Cytori Therapeutics
-
14.7.1 Cytori Therapeutics Company Details
-
14.7.2 Cytori Therapeutics Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cytori Therapeutics Kaposi's Sarcoma Product and Service
-
14.8 Aphios
-
14.8.1 Aphios Company Details
-
14.8.2 Aphios Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aphios Kaposi's Sarcoma Product and Service
-
14.9 Johnson and Johnson
-
14.9.1 Johnson and Johnson Company Details
-
14.9.2 Johnson and Johnson Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson and Johnson Kaposi's Sarcoma Product and Service
-
14.10 Merck
-
14.10.1 Merck Company Details
-
14.10.2 Merck Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck Kaposi's Sarcoma Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kaposi's Sarcoma
-
Figure Kaposi's Sarcoma Picture
-
Table Global Kaposi's Sarcoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kaposi's Sarcoma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kaposi's Sarcoma Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kaposi's Sarcoma Consumption by Country (2017-2022)
-
Figure United States Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Table Europe Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Figure China Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Figure Japan Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Figure India Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kaposi's Sarcoma Consumption and Growth Rate (2017-2022)
-
Figure Global Kaposi's Sarcoma Consumption Forecast by Country (2022-2028)
-
Figure United States Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kaposi's Sarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Classic Consumption and Growth Rate (2017-2022)
-
Figure Global Endemic Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppresion Therapy-related Consumption and Growth Rate (2017-2022)
-
Figure Global Epidemic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Institution Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Classic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endemic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppresion Therapy-related Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epidemic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kaposi's Sarcoma Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kaposi's Sarcoma Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kaposi's Sarcoma Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Kaposi's Sarcoma Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kaposi's Sarcoma Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Kaposi's Sarcoma Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Kaposi's Sarcoma Product and Service
-
Table CytRx (Foundation Year, Company Profile and etc.)
-
Table CytRx Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table CytRx Kaposi's Sarcoma Product and Service
-
Table Cytori Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Cytori Therapeutics Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytori Therapeutics Kaposi's Sarcoma Product and Service
-
Table Aphios (Foundation Year, Company Profile and etc.)
-
Table Aphios Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aphios Kaposi's Sarcoma Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Kaposi's Sarcoma Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Kaposi's Sarcoma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Kaposi's Sarcoma Product and Service
-
